AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed ...Middle East

AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed )

Also on site :

• Russian Drone Attack: Kyiv Under Siege
• High-Stakes Headlines: Airline Cancellations, NATO Spending, and Energy Bill Cuts
• Miranda Devine: Trump’s ‘spectacular’ Iran strike could carve his place in history as most courageous leader since Ronald Reagan